154
Participants
Start Date
November 30, 2001
Primary Completion Date
August 31, 2006
gemcitabine hydrochloride
Given IV
paclitaxel
Given IV
tipifarnib
Given orally
radiation therapy
Undergo radiation therapy
Radiation Therapy Oncology Group, Philadelphia
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH